NCT00310336View on ClinicalTrials.gov

Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Hepatitis C
Interventions
DRUG

S-adenosyl-L-methionine

DRUG

betaine

DRUG

pegylated interferon alpha2b

DRUG

ribavirin

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT00310336 - Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine | Biotech Hunter | Biotech Hunter